New England Securities’s Bristol-Myers Squibb BMY Stock Holding History

New England Securities’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q4	$505K	Sell	8,547 -23,864	-74%	-$1.35M	0.18%	143
2014 Q3	$1.66M	Sell	32,411 -169	-0.5%	-$8.44K	0.58%	30
2014 Q2	$1.58M	Buy	32,580 +1,121	+4%	+$55.2K	0.55%	35
2014 Q1	$1.63M	Buy	31,459 +578	+2%	+$30.8K	0.63%	28
2013 Q4	$1.64M	Buy	30,881 +1,913	+7%	+$97.4K	0.68%	27
2013 Q3	$1.34M	Buy	28,968 +3,114	+12%	+$137K	0.68%	28
2013 Q2	$1.16M	Buy	+25,854	New	+$1.12M	0.77%	24

Other funds holding BMY

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

LTI

Laffer Tengler Investments Nashville, Tennessee $782M AUM 33.6% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

New England Securities's BMY Position: Q4 2014 in Review

New England Securities reduced its Bristol-Myers Squibb (BMY) stake by 74% in Q4 2014, selling an estimated $1.35M and leaving 8,547 shares worth $505K. The position accounts for 0.18% of the portfolio, ranked #143.

New England Securities first reported a position in BMY in Q2 2013 and has held it in 7 quarters since. The position peaked at $1.66M in Q3 2014. 1,410 funds tracked by Wall St. Rank hold BMY as of Q4 2014.

New England Securities held 8,547 shares of Bristol-Myers Squibb worth $505K as of Q4 2014.
New England Securities sold 23,864 Bristol-Myers Squibb shares in Q4 2014, an estimated $1.35M.
Bristol-Myers Squibb made up 0.18% of New England Securities's portfolio in Q4 2014, its #143 holding.
New England Securities first reported a position in Bristol-Myers Squibb in Q2 2013 and has held it in 7 quarters since.
New England Securities's Bristol-Myers Squibb position peaked at $1.66M in Q3 2014.
1,410 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q4 2014.

Based on New England Securities's 13F filing for Q4 2014, filed 26 Jan 2015.